CA
NZ
UK
AU
IND
US
● STERIS has quietly become one of the most dependable operators in healthcare infrastructure, and in September 2026 the stock sits near $215 with a marketCapitalizationnorth of $20 billion on the New York Stock Exchange.
Priced at a fraction of a cent, Stemtech Corporation (OTC:STEK) is about as far down the market-cap ladder as a listed company can go. The wellness and nutrition marketer, which sells plant-based stem-cell support supplements, trades on the OTC Pink tier at roughly $0.0001 …
● Neuronetics offered a rare upbeat signal on an otherwise cautious tape, with STIM shares ticking higher as the maker of NeuroStar transcranial magnetic stimulation therapy pushes toward profitability.
● Headquartered in Piombino Dese near Padua, Stevanato traces its roots to a glassmakingBusinessfounded in 1949 and today spans two segments: Biopharmaceutical and Diagnostic Solutions, which supplies drug-containment and delivery products, and Engineering, which builds assembly and inspection machinery.
The company behind the HydraFacial treatment has spent the past two years working to stabilize aBusinessthat grew fast and then stumbled. Now trading as SkinHealth Systems Inc. (NASDAQ: SKIN) after rebranding from The Beauty Health Company in April 2026, the Nasdaq-listed aesthetics group is …
Behind a fractional uptick in one of the market's smallest biotechs sits an ambitious clinical bet: silencing one of oncology's most notorious drivers. Silexion Therapeutics Corp (NASDAQ: SLXN), a nano-cap developer of RNA-interference therapies, edged higher in its latest session even as itsMarket Valuesits …
After a long stretch as an over-the-counter name, SANUWAVE Health, Inc. (NASDAQ:SNWV) has spent 2026 navigating life as a Nasdaq-listed medical-device company, and the transition has come with turbulence. The advanced wound-care specialist has posted strong consumableDemandwhile grappling with reimbursement pressure that has weighed …
Spencer Pharmaceutical Inc. (OTC:SPPH) is a ticker that carries more history than substance. Quoted at essentially a hundredth of a cent with aMarket Valuein the low hundreds of dollars in the last closing session, SPPH is a dormant deep-penny name whose most notable legacy …
● With aMarket Valueof under $3 million and fewer than 600,000 shares outstanding, SciSparc sits at the extreme small end of the biotech spectrum, where even minor trades can swing the price.
ARS Pharmaceuticals, Inc (NASDAQ:SPRY) has become one of the more closely followed commercial-stage names in the allergy space, largely on the back of neffy, its needle-free epinephrine nasal spray. Yet the stock has come under pressure in recent weeks, sliding toward the low-$5 range …
Please wait processing your request...